1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice
(
- Contribution to journal › Article
- 2019
-
Mark
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species
2019) In Proceedings of the National Academy of Sciences of the United States of America 166(22). p.10943-10951(
- Contribution to journal › Article